Induction of Fas expression on human lymphoid cells by HCV infection.

被引：0
|
作者：
Taya, N [1 ]
Torimoto, Y [1 ]
Hirai, K [1 ]
Satoh, K [1 ]
Ohnishi, K [1 ]
Hasebe, C [1 ]
Kohgo, Y [1 ]
机构：
[1] ASAHIKAWA MED COLL,DEPT INTERNAL MED,ASAHIKAWA,HOKKAIDO 078,JAPAN
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2976 / 2976
页数：1
相关论文
共 50 条
  • [1] Characteristics of Fas ligand expression by human cytomegalovirus infection.
    Hwnag, ES
    Kim, JH
    Kwon, YJ
    Jung, HJ
    Kim, SY
    Park, CG
    Cha, CY
    CLINICAL IMMUNOLOGY, 2005, 115 : S164 - S164
  • [2] Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein
    Ruggieri, A
    Murdolo, M
    Rapicetta, M
    VIRUS RESEARCH, 2003, 97 (02) : 103 - 110
  • [3] Primary human hepatocytes and their role in modeling HCV infection.
    King, CS
    Pruett, TL
    LIVER TRANSPLANTATION, 2005, 11 (07) : C2 - C2
  • [4] Rag-/- mice transplanted with human liver cells:: A model for HAV or HCV infection.
    Funkhouser, AW
    Vahed, S
    O Gorman, M
    Soriano, HE
    HEPATOLOGY, 1999, 30 (04) : 188A - 188A
  • [5] Peptide-specific CTL induction in patients with chronic HCV infection.
    Ohno, T
    Mizokami, M
    Orito, E
    Kondo, Y
    Kato, H
    Sugauchi, H
    Kimura, Y
    Suzuki, S
    Ueda, R
    HEPATOLOGY, 2000, 32 (04) : 572A - 572A
  • [6] Telaprevir for Chronic HCV Infection.
    van der Meer, Adriaan J. P.
    de Knegt, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (05): : 533 - 534
  • [7] HCV core antigen: A new marker of HCV infection.
    Bouvier-Alias, M
    Patel, K
    Beaucourt, S
    Larderie, P
    Blatt, LM
    Dhumeaux, D
    McHutchison, JG
    Pawlotsky, JM
    HEPATOLOGY, 2001, 34 (04) : 227A - 227A
  • [8] Development and clinical evaluation of human monoclonal antibodies for treating HCV infection.
    Eren, R
    Ilan, E
    Nussbaum, O
    Neville, L
    Arazi, Y
    Gopher, J
    Kitzis-Livneh, G
    Zauberman, A
    Lurie, Y
    Akerman, Z
    Galun, E
    Dagan, S
    HEPATOLOGY, 2002, 36 (04) : 287A - 287A
  • [9] Immunogenetic markers and the course of HCV infection.
    Lio, D
    Almasio, PL
    Romano, GC
    Candore, G
    Valenza, ML
    Di Pisa, M
    D'Antona, F
    Ferraro, D
    Caruso, C
    Craxi, A
    HEPATOLOGY, 2000, 32 (04) : 273A - 273A
  • [10] Thrombocytopenia associated with HCV viral infection.
    Loustaud-Ratti, V
    Riche, A
    Jauberteau, MO
    Soria, P
    Liozon, E
    Ranger, S
    Labrousse, F
    Vidal, E
    HEPATOLOGY, 1999, 30 (04) : 591A - 591A
12345